These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 34931698)

  • 21. Hair disorders associated with post-COVID-19 infection in females: a cross-sectional study.
    Awad NEHA; Obaid ZM; Zaky MS; Elsaie ML
    Ir J Med Sci; 2024 Apr; 193(2):761-767. PubMed ID: 37704885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Alopecia in patients with COVID-19: A systematic review and meta-analysis.
    Nguyen B; Tosti A
    JAAD Int; 2022 Jun; 7():67-77. PubMed ID: 35224518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Time of onset and duration of post-COVID-19 acute telogen effluvium.
    Abrantes TF; Artounian KA; Falsey R; Simão JCL; Vañó-Galván S; Ferreira SB; Davis TL; Ridenour W; Goren A; Tosti A; Wambier CG
    J Am Acad Dermatol; 2021 Oct; 85(4):975-976. PubMed ID: 34302903
    [No Abstract]   [Full Text] [Related]  

  • 24. Red nail bands in conjunction with telogen effluvium as a post-COVID-19 phenomenon.
    Thakur V; Bisht YS; Sethi S; Jindal R
    Australas J Dermatol; 2022 Feb; 63(1):141-142. PubMed ID: 34958136
    [No Abstract]   [Full Text] [Related]  

  • 25. Characteristics of telogen effluvium in COVID-19 in western Iran (2020).
    Babaei K; Kavoussi H; Rezaei M; Kavoussi R
    An Bras Dermatol; 2021; 96(6):688-692. PubMed ID: 34593265
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Telogen Effluvium - a review of the science and current obstacles.
    Chien Yin GO; Siong-See JL; Wang ECE
    J Dermatol Sci; 2021 Mar; 101(3):156-163. PubMed ID: 33541773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trichotillomania: Bizzare Patern of Hair Loss at 11-Year-old Girl.
    Zímová J; Zímová P
    Acta Dermatovenerol Croat; 2016 Jun; 24(2):150-3. PubMed ID: 27477178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Female pattern alopecia and telogen effluvium: figuring out diffuse alopecia.
    Torres F; Tosti A
    Semin Cutan Med Surg; 2015 Jun; 34(2):67-71. PubMed ID: 26176282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between hair shedding and systemic inflammation in COVID-19 pneumonia.
    Guarnieri G; Bertagna De Marchi L; Marcon A; Panunzi S; Batani V; Caminati M; Furci F; Senna G; Alaibac M; Vianello A
    Ann Med; 2022 Dec; 54(1):869-874. PubMed ID: 35341398
    [No Abstract]   [Full Text] [Related]  

  • 30. Characteristics of hair loss in COVID-19 patients in Thailand.
    Triwongwaranat D; Thanomkitti K; Korviriyakamol T; Saengthong-Aram P; Varothai S; Thuangtong R
    Medicine (Baltimore); 2023 Dec; 102(49):e36539. PubMed ID: 38065902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chronic Telogen Effluvium: Is it a Distinct Condition? A Systematic Review.
    Daunton A; Harries M; Sinclair R; Paus R; Tosti A; Messenger A
    Am J Clin Dermatol; 2023 Jul; 24(4):513-520. PubMed ID: 37052778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Post Covid telogen effluvium: the diagnostic value of serum ferritin biomarker and the preventive value of dietary supplements. a case control study.
    Bedair NI; Abdelaziz AS; Abdelrazik FS; El-Kassas M; AbouHadeed MH
    Arch Dermatol Res; 2024 Jun; 316(6):336. PubMed ID: 38844670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of SARS-CoV-2 infection and its vaccines in various types of hair loss.
    Aryanian Z; Balighi K; Hatami P; Afshar ZM; Mohandesi NA
    Dermatol Ther; 2022 Jun; 35(6):e15433. PubMed ID: 35266262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence of Hair Loss After COVID-19 Infection in Makkah Region, Saudi Arabia.
    Abdulwahab RA; Aldajani BM; Natto NK; Janabi AM; Alhijaili OI; Faqih NT; Alharbi A
    Cureus; 2022 Sep; 14(9):e29285. PubMed ID: 36277546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patients with profuse hair shedding may reveal anagen hair dystrophy: a diagnostic clue of alopecia areata incognita.
    Quercetani R; Rebora AE; Fedi MC; Carelli G; Mei S; Chelli A; Poli E
    J Eur Acad Dermatol Venereol; 2011 Jul; 25(7):808-10. PubMed ID: 20946585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and histological challenge in the differential diagnosis of diffuse alopecia: female androgenetic alopecia, telogen effluvium and alopecia areata--part II.
    Werner B; Mulinari-Brenner F
    An Bras Dermatol; 2012; 87(6):884-90. PubMed ID: 23197208
    [TBL] [Abstract][Full Text] [Related]  

  • 37. COVID-19-associated Telogen Effluvium After Hospital Discharge: A Prospective Cohort Study.
    Damevska K; Sotirovski T; Batkoska B; Djambazova M; Radeski V; Simonoska J; Bachevski D; Rushiti Mehmeti K; Popovski T; Labenishta E; Ristovski A; Najdova A
    Acta Dermatovenerol Croat; 2024 Mar; 32(1):33-38. PubMed ID: 38946185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histopathologic features of alopecia areata incognito: a review of 46 cases.
    Miteva M; Misciali C; Fanti PA; Tosti A
    J Cutan Pathol; 2012 Jun; 39(6):596-602. PubMed ID: 22616601
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Need to Analyze Telogen Effluvium and Alopecia Areata Parallelly in Long COVID Studies.
    Weng CT; Wei KC; Yang CC
    Influenza Other Respir Viruses; 2024 Jul; 18(7):e13356. PubMed ID: 39057605
    [No Abstract]   [Full Text] [Related]  

  • 40. Dermoscopy-assisted prevalence of hair loss after COVID-19 vaccination among an Egyptian population: a cross-sectional study.
    Ammar AM; Ibrahim IS; Mohamed AN; Elsaie ML
    Ir J Med Sci; 2024 Apr; 193(2):755-760. PubMed ID: 37580623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.